Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)

被引：70
|
作者：
Dresser, MJ
Xiao, GQ
Leabman, MK
Gray, AT
Giacomini, KM [1 ]
机构：
[1] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA
来源：
PHARMACEUTICAL RESEARCH | 2002年 / 19卷 / 08期
关键词：
transporter; organic cation; selectivity; metformin; phenformin;
D O I：
10.1023/A:1019870831174
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
[No abstract available]
引用
收藏
页码：1244 / 1247
页数：4
相关论文
共 37 条
  • [31] Renal Secretion of Uric Acid by Organic Anion Transporter 2 (OAT2/SLC22A7) in Human
    Sato, Masanobu
    Mamada, Hideaki
    Anzai, Naohiko
    Shirasaka, Yoshiyuki
    Nakanishi, Takeo
    Tamai, Ikumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2010, 33 (03) : 498 - 503
  • [32] Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2)
    Szabo, Kitti
    Nagy, Zoltan
    Juhasz, Viktoria
    Zolnerciks, Joseph K.
    Csorba, Attila
    Timar, Zoltan
    Molnar, Eva
    Padar, Petra
    Johnson, William
    Beery, Erzsebet
    Krajcsi, Peter
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (03) : 165 - 171
  • [33] Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
    Kawoosa, Fizalah
    Shah, Zafar A.
    Masoodi, Shariq R.
    Amin, Asif
    Rasool, Roohi
    Fazili, Khalid M.
    Dar, Abid Hamid
    Lone, Asif
    ul Bashir, Samir
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [34] Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes
    Fizalah Kawoosa
    Zafar A. Shah
    Shariq R. Masoodi
    Asif Amin
    Roohi Rasool
    Khalid M. Fazili
    Abid Hamid Dar
    Asif Lone
    Samir ul Bashir
    BMC Endocrine Disorders, 22
  • [35] Competitive Inhibition of the Luminal Efflux by Multidrug and Toxin Extrusions, but Not Basolateral Uptake by Organic Cation Transporter 2, Is the Likely Mechanism Underlying the Pharmacokinetic Drug-Drug Interactions Caused by Cimetidine in the Kidney
    Ito, Sumito
    Kusuhara, Hiroyuki
    Yokochi, Miyu
    Toyoshima, Junko
    Inoue, Katsuhisa
    Yuasa, Hiroaki
    Sugiyama, Yuichi
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 340 (02): : 393 - 403
  • [36] Involvement of Human Organic Cation Transporter 1 in the Hepatic Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel, Small Molecule Survivin Suppressant
    Iwai, Megumi
    Minematsu, Tsuyoshi
    Narikawa, Shinichi
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) : 1856 - 1863
  • [37] Characterization of Human Organic Cation Transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-Mediated Transport of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small Molecule Survivin Suppressant
    Minematsu, Tsuyoshi
    Iwai, Megumi
    Umehara, Ken-Ichi
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) : 1 - 4
1234